To lose weight, you need to be in a calorie deficit. However, it's not as simple as consuming fewer calories. Depending on your physical activity, age, calories burned and more factors, a calorie ...

An expert Cleveland Clinic doctor reveals how much weight you can safely lose in a month and strategies to help you achieve lasting results.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Nancy McKeon admits “there was a lot” of talk about the cast’s weight behind the scenes on “The Facts of Life.” While McKeon ...

A couple of months ago, healthcare equity research analyst Jared Holz from Mizuho spoke about Viking potentially being an ...

April prices were down 10cts to $77.46/bbl. U.S. crude prices are set to end the week nearly 4% lower while Brent is on track to settle down about 3% from last Friday. Gasoline futures were moving ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.

We can take away from this research that 150 minutes of moderate-intensity or greater aerobic exercise per week might be necessary if you want to see more meaningful weight loss. Exercising for ...

Novo Nordisk has reported 22% weight loss in people who received weekly amycretin injections for 36 weeks, triggering an 11% jump in the Danish drugmaker’s share price in premarket trading.

On Friday, Novo Nordisk A/S (NYSE:NVO) released topline results from a phase 1b/2a trial with amycretin intended for once-weekly subcutaneous ... body weight of 92.7 kg, people treated with amycretin ...